Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SeegnalTSXV:SEGN 2 EV-to-FCF is -5.05 as of Aug. 03, 2026. GuruFocus rates TSXV:SEGN with a GF Score™ of 2/100. The stock has 3 warning signs investors should review. Among 405 Healthcare Providers & Services companies, Seegnal ranks worse than 246913.33% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Seegnal's Enterprise Value is C$19.99 Mil.
Seegnal's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was C$-3.95 Mil. Therefore, Seegnal's EV-to-FCF for today is -5.05.
The historical rank and industry rank for Seegnal's EV-to-FCF or its related term are showing as below:
TSXV:SEGN'
s EV-to-FCF Range Over the Past 10 Years
Min: -24.79 Med: -5.5 Max: -2.76
Current: -5.06
During the past 2 years, the highest EV-to-FCF of Seegnal was -2.76. The lowest was -24.79. And the median was -5.50.
TSXV:SEGN's EV-to-FCF is ranked worse than 100% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 17.83
vs TSXV:SEGN: -5.06
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-08-03), Seegnal's stock price is C$0.28.
Seegnal's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was C$-0.315. Therefore, Seegnal's PE Ratio (TTM) for today is At Loss.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Seegnal's share price for today is C$0.28.
Seegnal's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.315.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Seegnal EV-to-FCF Related Terms
Seegnal EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Seegnal's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSXV:SEGN vs VEEV, BTSG, HQY: EV-to-FCF Comparison
For the Health Information Services subindustry, Seegnal's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Seegnal EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Seegnal's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Seegnal's EV-to-FCF falls into.
Seegnal's current Enterprise Value is C$19.99 Mil.
Seegnal's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-3.95 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Seegnal (TSXV:SEGN) has a EV-to-FCF of -5.05 as of Aug. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Seegnal and its competitors. According to the industry distribution chart, Seegnal ranks #999999 out of 405 companies in the Healthcare Providers & Services industry.
Is Seegnal's EV-to-FCF too high?
Seegnal's current EV-to-FCF is -5.05. Based on the distribution chart, Seegnal ranks #999999 out of 405 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Seegnal has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does Seegnal's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Seegnal ranks #999999 out of 405 companies for EV-to-FCF. This places Seegnal in the lower half of its industry. The industry median EV-to-FCF is 17.83. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.83, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Seegnal and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Seegnal's current EV-to-FCF is -5.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seegnal stock overvalued right now?
Seegnal (TSXV:SEGN) has a current EV-to-FCF of -5.05. The current EV-to-FCF is -5.05. Seegnal's overall GF Score™ is 2/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Seegnal (TSXV:SEGN), the current EV-to-FCF is -5.05 as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Seegnal Inc is a med-tech software as a service (SaaS) company focused on the development and commercialization of a patient-centric clinical decision support system designed to mitigate drug-related problems at the point of care. It provides AI-enhanced clinical decision support software that helps healthcare providers prescribe medications safely and efficiently at the point of care (the Seegnal Platform). It analyzes patient-specific clinical data and medication regimens in real time to identify potential drug-related risks, including drug-drug interactions, contraindications, and adverse drug events. By integrating with electronic medical record systems, its platform supports clinicians in improving patient safety, optimizing medication use, and reducing healthcare costs.
2GF Score
Get the complete analysis for TSXV:SEGN
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:SEGN has been successfully added to your 
